CASSS – Sharing Science Solutions is excited to announce thirty-four new Associate Directors (ADs) will be joining the CASSS leadership. These ADs will join a large and diverse group of volunteers who represent the various communities that comprise the organization. The ADs advise the board on issues of importance to the membership-at-large. One of the most important responsibilities of this volunteer group is to elect the Board of Directors.
"What draws me to CASSS is the coming together of talented scientists from different backgrounds and technical areas to identify and overcome inefficiencies and roadblocks that impede the ultimate goal which is to deliver safe and effective medicines to patients globally with a heartfelt, borderless mindset." –Marla Abodeely
One of the priorities of the Board has been to broaden member participation at all levels. If you have volunteered on any CASSS organizing committee, you are invited to become an Associate Director and further help direct
the future of CASSS. Together, our volunteers advance the CASSS community in the direction of dignity, respect, scientific truth, and the betterment of humanity.
According to CASSS’ bylaws, the Associate Director’s responsibilities include:
- Advise the Board of Directors on policy and strategic direction for the organization.
- Elect the Board of Directors.
- Have a direct impact on CASSS’ future.
We would like to thank our new ADs for joining our CASSS leadership.
(NOTE: click on the bolded names below to view their past participation in CASSS projects.)
- Marla Abodeely*, Sanofi
- Svetlana Bergelson*, Biogen
- Vanja Cankovic, CHIESI Farmaceutici S.p.A.
- Mohamed Dawod*, IGM Biosciences, Inc.
"CASSS always provides a substantial opportunity to its members to gain and grow knowledge through sharing resources across a massive array of symposia.” –Mohamed Dawod
- Isabella de Jong*, Genentech, a Member of the Roche Group
- Sydia Dunkley, F. Hoffmann-La Roche Limited
- Christoph (CJ) Gstottner*, Leiden University Medical Center
- Kowid Ho, F. Hoffmann-La Roche AG
- Goran Huebner, Boehringer Ingelheim Pharma GmbH & Co. KG
- Felix Jules*, Health Canada
- Richard Keane, Biogen Idec Limited
- Babu Kunnel*, Arcus Biosciences, Inc.
- Andrew Lennard, Amgen Inc.
- Jennifer Litowski, Amgen Inc.
- Jing Liu*, Pfizer, Inc.
- Elkiane Macedo Rama, ANVISA
- Joan Malmstrom, Novo Nordisk A/S
- Frances Namuswe*, CDER, FDA
- Christiane Niederlaender, Parexel International
- Kevin Okimura*, Orca Bio
"I feel honored to be a part of this diverse community, where all are welcome.” –Kevin Okimura
- Crystal Pannucci, Eli Lilly and Company
- Raj Poudel, Tune Therapeutics
- Da Ren, BioTherapeutics Solutions
- Tara Sanderson, UCB Celltech
"This is such a wonderful opportunity that CASSS provides, and it is always great welcoming new members to the CASSS family." –Tara Sanderson
- Hillary Schuessler, Merck & Co., Inc.
- Madhu Siluveru, Merck & Co., Inc.
- Bryan Silvey, A2 Biotherapeutics, Inc.
- Tara Stauffer, Bristol-Myers Squibb Company
"CASSS is integral to current biopharmaceutical development." –Tara Stauffer
- Zenobia Taraporewala, BioMarin Pharmaceutical Inc.
- Vicky Van Klinken-Manti, Merck Sharp & Dohme Biotech B.V.
- Leslie Wagner, CBER, FDA
- Mats Wikstroem, Amgen Inc.
- Diane Wilkinson*, AstraZeneca
- Nailing Zhang, CDER, FDA
The CASSS Board of Directors looks forward to your direct impact on CASSS’ future and strategic direction of the organization.
*Included in the Associate Director's image above.